Alcon
Alcon manufactures intraocular lenses, which replace the natural lens removed during cataract surgery. It is the second largest division of Swiss group Novartis.
Alcon operates in more than 75 countries, serving 180 markets and employing more than 24,000 people. The Cork centre manufactures AcrySof® intraocular lenses, the most frequently implanted lenses worldwide.
Technologies and processes featured at the Cork site include mould-tool manufacturing, monomer formulation, casting, curing/polymerization, high precision optical measurement and packaging. Approximately 400 employees work at the site.
Financial Data
-
31st Dec 18 Source: CRO
- €58.7 million turnover
-
€2.3 million
profit - 413 employees
-
31st Dec 17 Source: CRO
- €46.4 million turnover
-
€1.5 million
profit - 404 employees
- 5 more years available »
Ranking
By Turnover
(€58.7 million)- 648th in Top Companies
- 63rd in Pharma
By Employees
(413)- 412th in Top Companies
- 34th in Pharma
- 413
- €58.7 million
Employees
- Jackie Murphy Country Manager
Latest News
- May 24 Harsh winter may compel Europe to ration gas, warns International Energy Agency
- May 24 Hungary and Poland hold up EU decisions on oil and corporate tax
- May 24 Over 700 objections lodged against €466m Dundrum apartment ‘concrete jungle’
- May 24 Stripe unveils new third party app marketplace
- May 24 Shares in UK energy companies slide over windfall tax fears